Loading
Latest filing published 03 Feb 2022 for Omega Therapeutics, Inc., €5,333. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Mahesh Karande is known so far (3 February 2022): an option exercise, €5,333, in Omega Therapeutics, Inc. That is too little to draw conclusions. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration